Figure 6
From: Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
Sensitivity analysis for the cost per QALY gained for baseline testing, varying chlamydia treatment effectiveness. Baseline testing strategy is 16.8% overall testing coverage and 0.4 partner notification efficacy. The cost per QALY gained is compared to no testing.